Peripheral Neuropathy Trial, Recruiting NCT06264297 Sponsor: Consorci Sanitari de Terrassa Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT06264297
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People experiencing pain on one side of the body that shoots or radiates down into a leg (with or without lower back pain), following the path of specific nerve routes
  • People whose symptoms match what is visible on an MRI scan
  • People who have had this type of radiating nerve pain for three months or longer
  • People who have had a nerve-related electrical test (EMG), whether the result was normal or showed a problem
  • People whose pain has been identified as nerve-type pain using a specific questionnaire called the DN4
  • People who have already had a diagnostic nerve-blocking procedure that gave a positive result
  • People who have signed a consent form agreeing to take part in the trial

Who may not be able to join:

  • People under 18 years of age
  • People whose lower back pain does not involve nerve pain radiating down the leg
  • People whose MRI results do not match their reported symptoms
  • People who have a condition affecting the nerves throughout their lower limbs generally (peripheral neuropathy)
  • People with a history of, or a current diagnosis of, a serious mental health condition
  • People with moderate or severe difficulties with thinking or memory, or signs of a sudden-onset confused mental state
  • People who have an infection at the area where an injection would be given
  • People who have a condition affecting how their blood clots
  • People who are pregnant
  • People who do not wish to sign the consent form
  • People who have an allergy to the dye used in imaging procedures (radiological contrast)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +34650528215

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Consorci Sanitari de Terrassa
Registry
ClinicalTrials.gov
Start date
20 February 2023
Est. completion
1 January 2027

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

OSWESTRY LOW BACK DISABILITY QUESTIONNAIRE

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov